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Background. Circumcision and lower human papillomavirus (HPV) viral loads in men are possibly associated
with a reduced risk of HPV transmission to women. However, the association between male circumcision and HPV
viral load remains unclear.
Methods. Swab specimens from the glans and shaft of the penis were collected from men enrolled in a circum-
cision trial in Kisumu, Kenya. GP5+/6+ polymerase chain reaction (PCR) was used to identify HPV DNA types.
HPV-16 and HPV-18 loads were measured with a LightCycler real-time PCR and classified as high (>250 copies/
scrape) or low (≤250 copies/scrape).
Results. A total of 1159 men were randomly assigned to undergo immediate circumcision, and 1140 men were
randomly assigned to the control arm (these individuals were asked to remain uncircumcised until the study ended).
The hazard of acquisition of high-viral load infections in the glans was lower in the circumcision arm, compared with the
control arm, for HPV-16 (hazard ratio [HR], 0.32 [95% confidence interval {CI}, .20–.49]) and HPV-18 (HR, 0.34 [95%
CI, .21–.54]). The 6-month risk of HPV persistence among men with high-viral load infections in the glans at baseline
was lower in the circumcision arm, compared with the control arm, for HPV-16 (risk ratio [RR], 0.36 [95% CI, .18–.72])
and HPV-18 (RR 0.34 [95% CI, .13–.86]). Weaker and less precise results were obtained for shaft samples.
Conclusions. Male circumcision could potentially reduce the risk of HPV transmission to women by reducing the
hazard of acquisition, and the risk of persistence of high-HPV viral load infections in the glans in men.
Keywords. male circumcision; human papillomavirus (HPV); viral load; HPV-16; HPV-18; men; randomized
controlled trial (RCT), incidence; persistence; Kenya.
Persistent infections with high-risk human papilloma-
virus (HPV) type 16 (HPV-16) and HPV-18 are causes
of approximately 70% of cervical cancer cases in women
[1]. Women with higher HPV-16 or HPV-18 loads are
more likely to have persistent infections and to progress
to high-grade cervical intraepithelial neoplasia than
those with lower viral loads [2–8]. Men with higher
HPV-16 or HPV-18 loads have a higher prevalence of
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flat penile lesions and greater HPV type concordance with their
female partners than those with lower viral loads [9–11]. As a
result, a higher HPV viral load in men is suggested to be asso-
ciated with an increased risk of HPV transmission to their fe-
male partners [9].
Male circumcision has been found to be protective against
human immunodeficiency virus (HIV) and penile HPV infec-
tions [12–18]. Three randomized controlled trials (RCTs) in
Kenya, Uganda, and South Africa, as well as several longitudinal
studies, have shown that high-risk HPV prevalence in circum-
cised men is lower than that in uncircumcised men [15–18].
RCTs in Kenya and Uganda also found that male circumcision
reduces the acquisition of high-risk HPV infections and en-
hances clearance of HPV infections over 24 months [16, 17].
The prevalence of flat penile lesions after 24 months in circum-
cised men was lower than that in uncircumcised men in the
Kenya trial [10]. Among HIV-negative men in the Uganda
trial, a lower HPV prevalence was observed in female partners
of circumcised men, compared with female partners of uncir-
cumcised men [19]. Circumcision and lower HPV viral load
inmen are suggested to be associated with a reduced risk of HPV
transmission to women, but the association between male cir-
cumcision and HPV viral load remains unclear [9].
To our knowledge, only the RCT in Uganda has examined the
effect of male circumcision on penile HPV viral load [20]. This
study, however, did not examine the association between male cir-
cumcision and the hazard of acquisition of high-HPV viral load
infections, or the prevalence of high-viral load HPV infections ver-
sus low-viral load HPV infections amongmen with incident HPV
infections. Also, the association between circumcision and the per-
sistence of high-viral load and low-viral load HPV infections pre-
sent at baseline (prevalent infections) has not yet been examined.
We present the results of an RCT examining the associations
between male circumcision and the incidence and risk of persis-
tence of high-viral load and low-viral load HPV-16 and HPV-
18 infections in men from Kisumu, Kenya. We have previously
shown that male circumcision reduces the incidence and in-
creases the clearance of HPV infections in this population
[16]; here we expand on those findings to examine the effect
of male circumcision on HPV viral load.
METHODS
Study Population and Enrollment
Uncircumcised men were screened between 4 February 2002
and 6 September 2005 in Kisumu to participate in an RCT of
male circumcision (clinical trials registration NCT00059371)
[14]. The main aim of the trial was to determine the effective-
ness of male circumcision in reducing the incidence of HIV infec-
tion. Study methods have been previously described in detail [14].
Briefly, study inclusion criteria included being uncircumcised,
having an age of 18–24 years, testing negative for HIV, being
sexually active within the past 12 months, and having a blood
hemoglobin level of ≥90 g/L. Participants who met the study
criteria were randomly assigned to either the circumcision
arm and to undergo immediate circumcision or the control
arm and to remain uncircumcised until the end of their 24
months of study participation. This study protocol was ap-
proved by institutional review boards of the universities of Illi-
nois-Chicago, Manitoba, Nairobi, and North Carolina; RTI
International; and VU University Medical Center.
This present analysis includes men from the RCT who con-
sented to the collection of penile exfoliated cells and their ship-
ment overseas for HPV DNA and HPV viral load testing. Of the
2784 men enrolled in the RCT, 2299 (83%) consented to pro-
vide penile swab samples and had baseline HPV data; 1159
men were in the circumcision arm, and 1140 were in the control
arm (Figure 1). Eligibility for inclusion in incidence and persis-
tence analyses was determined for each HPV type (HPV-16 or
HPV-18) and anatomical site (glans or shaft) separately. Partic-
ipants who were (1) positive for HPV-16 or HPV-18 at baseline,
(2) had no HPV follow-up data, or (3) had missing HPV viral
load data were excluded from incidence analyses for that specif-
ic HPV type and anatomical site. Similar proportions of sam-
ples in the circumcision and control arms were included in
incidence analyses for HPV-16 (87% and 89%, respectively, in
glans samples and 90% and 93%, respectively, in shaft samples)
and HPV-18 (91% and 93%, respectively, in glans samples and
93% and 95%, respectively, in shaft samples). The persistence of
prevalent high-HPV viral load and low-HPV viral load infec-
tions was examined in participants who were (1) positive for
HPV-16 and/or HPV-18 at baseline, (2) had follow-up HPV
data, and (3) had viral load data for that HPV type and anatomical
site (for HPV-16, 144 [82.2%] and 67 [77.9%] had data for glans
and shaft specimens, respectively; for HPV-18, 60 [75.9%] and 24
[80%] had data for glans and shaft specimens, respectively).
Follow-up and Specimen Collection
Participant follow-up visits were scheduled every 6 months for a
period of 24 months. A standardized questionnaire on sociode-
mographic characteristics and sexual behavior was administered
by a trained male interviewer at each visit [14]. Penile exfoliated
cell specimens were collected by a trained physician or clinical
officer at each study visit [21]. Samples were collected from two
anatomical sites: (i) penile shaft and external foreskin (shaft
specimen); and (ii) glans, coronal sulcus, and the internal tissue
of the foreskin (glans specimen). Sampling of the foreskin was
conducted only in uncircumcised men. Two pre-wetted type 3
Dacron swabs were used to collect penile exfoliated cells from
the two separate anatomical sites. Samples were individually
processed in the clinic laboratory on the same day they were col-
lected and stored at −75°C [21]. All samples were transported
via Fedex in a liquid nitrogen dry shipper from Kisumu to the
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Department of Pathology at VU University Medical Center in
Amsterdam, Netherlands, for HPV DNA testing.
HPV DNA, HIV, and Sexually Transmitted Infection Testing
DNAwas isolated from penile exfoliated cell samples, using the
NucleoSpin 96 Tissue kit (Macherey-Nagel, Germany) and a
Microlab Star robotic system (Hamilton, Germany) according
to the manufacturers’ instructions. The presence of human
DNAwas evaluated by β-globin–specific polymerase chain reac-
tion (PCR), followed by agarose gel electrophoresis [22]. HPV
positivity was assessed by GP5+/6+ PCR, followed by hybridi-
zation of PCR products, using an enzyme immunoassay readout
with 2 HPV oligoprobe cocktail probes that detect 44 HPV
types. Subsequent HPV genotyping was performed by reverse
line blot hybridization of PCR products [22, 23].
HIV testing was performed at each visit, using 2 HIV anti-
body rapid tests (Determine, Abbott Diagnostic Division,
Hoofddorp, the Netherlands; and Unigold, Trinity Biotech,
Wicklow, Ireland), and confirmed by double enzyme-linked im-
munosorbent assay (ELISA; Adaltis, Montreal, Canada; Trinity
Biotech, Wicklow, Ireland) at the University of Nairobi [14].
Urine samples at each visit were tested for Trichomonas vagina-
lis, Neisseria gonorrhoeae, and Chlamydia trachomatis infec-
tions by PCR-based methods (Roche Diagnostics), and serum
was tested for herpes simplex virus 2 antibodies by a type-
specific ELISA (Kalon).
HPV Viral Load Testing
HPV DNA viral load testing was performed on penile exfoliated
cell samples that contained HPV-16 and/or HPV-18, using a
real-time PCR assay and a LightCycler instrument (Roche,
Mannheim, Germany) [24]. DNA extraction and purification
were conducted according to manufacturer instructions, using
100 µL of the remaining cell suspensions. All samples were run
in duplicate in the same run, and resulting values were averaged.
Dilutions of cloned HPV DNAwere used to determine the stan-
dard curve for the HPV target. To calculate the number of copies
per sample, the measured amount of detected HPV DNA from
the standard curve (expressed in femtograms) was divided by 44
(since 1 femtogram of HPV DNA was considered to contain 44
viral DNA copies) and multiplied by the dilution factor [9]. The
HPV viral load was categorized as low (≤250 copies/scrape) or
high (>250 copies/scrape). The 250 copies/scrape cut point for
high versus low viral loads was chosen because with this cut
point, high HPV viral loads (>250 copies/scrape) in men have
been associated with a higher prevalence of flat penile lesions,
as well as with increased HPV type concordance in their female
partners, compared with low HPV viral loads [9, 10].
Statistical Analyses
All analyses were performed for each HPV type (HPV-16
or HPV-18) and anatomical site (glans or shaft) separately.
Intent-to-treat analyses were performed to examine the incidence
Figure 1. Study flow chart of human papillomavirus (HPV) samples included in analyses of the effect of male circumcision on penile HPV viral load.
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of high-HPV viral load infections in circumcision versus con-
trol arms. Men who were randomly assigned to the circumci-
sion arm but were not circumcised (n = 23) and those
randomly assigned to the control arm but were circumcised
(n = 14) were included in the analysis in the group to which
they were randomly assigned. Incident penile HPV infections
were assumed to occur at the midpoint between the last
HPV-negative test result and the first subsequent HPV-positive
test result. Men who tested HPV negative at each visit were
censored at their last observed visit. Only the first incident
infections for each HPV type (HPV-16 or HPV-18) at each
anatomical site (glans or shaft) were included in incidence anal-
yses. The Kaplan–Meier method was used to estimate the
24-month cumulative risk of HPV-16 and HPV-18 in the
glans or shaft for the circumcision versus control arms. Hazard
ratios (HRs) comparing the rate of acquisition of high-viral load
infections in circumcision versus control arms were estimated
by fitting Cox proportional hazards models. For all incidence
analyses, HR estimates accounting for interval censoring were
obtained by fitting models assuming Weibull distributions for
incidence times; results obtained were similar to those from
the Cox models (data not shown).
An additional analysis was conducted among only participants
with incident HPV-16 or HPV-18 infections to examine associa-
tions between circumcision and the prevalence of high versus low
HPV viral loads at the time of HPV detection. Log binomial mod-
els were used to derive prevalence ratios (PRs) comparing the
prevalence of high versus low HPV viral loads at the time of
HPV detection for incident infections observed in the circumci-
sion versus control arms. Potential confounders of the association
between circumcision and HPV viral load were identified from
the literature and analyzed using a directed acyclic graph [25].
Clearance of prevalent infections detected at enrollment was
assumed to occur at the midpoint between the last HPV-
positive test result and the first subsequent HPV-negative test re-
sult. Men were censored at their last observed visit if they tested
positive at each consecutive visit for the same HPV type at the
same anatomical site. HPV persistence was defined as the detec-
tion of the same HPV type at the same anatomical site at 6
months after baseline in participants who were positive for
HPV-16 and/or HPV-18 at baseline. The Kaplan–Meier method
was used to estimate the cumulative risk of clearance for preva-
lent high-HPV viral load and low-HPV viral load infections. Risk
ratio (RR) estimates were calculated to compare the cumulative
risk of HPV persistence for prevalent infections in the circumci-
sion versus control arms at 6 months after baseline.
For all analyses of incidence and persistence, sensitivity
analyses were performed by restricting analyses to samples
that tested positive for the presence of human DNA by means
of the β-globin test. We also conducted sensitivity analyses to
examine incident HPV viral load as a continuous variable; spec-
imens with nonquantifiable HPV viral loads (ie, <250 copies/
scrape) were assumed to have HPV viral loads equal to 250 cop-
ies/scrape for these analyses. Differences in the distribution of










372 (33.9) 391 (35.6)
Any secondary or
above




94 (8.6) 98 (8.9)
Self-employed 303 (27.7) 294 (26.8)




1024 (93.8) 1018 (93.2)
Not married (with
live-in partner)
7 (0.6) 7 (0.6)
Married (not living
with wife)
5 (0.5) 15 (1.4)
Married (living with
wife)
56 (5.1) 52 (4.8)
Sex partners, no.
Lifetime historya 4 (3–7; 1–120) 4 (3–7; 1–86)
In previous 6 mo
0 137 (12.5) 136 (12.4)
1 472 (43.2) 472 (44.1)
≥2 484 (44.3) 475 (43.5)
Used a condom with intercourse in previous 6 mo
Always 210 (21.9) 208 (21.7)
Inconsistent 511 (53.3) 500 (52.1)
Never 238 (24.8) 251 (26.2)
Herpes simplex virus 2
Positive 287 (27.3) 278 (26.5)
Negative 764 (72.7) 771 (73.5)
Trichomonas vaginalis
Positive 21 (1.9) 24 (2.2)
Negative 1064 (98.1) 1059 (97.8)
Neisseria gonorrhoeae
Positive 30 (2.8) 17 (1.6)
Negative 1053 (97.2) 1066 (98.4)
Chlamydia trachomatis
Positive 57 (5.3) 42 (3.9)
Negative 1025 (94.7) 1041 (96.1)
Bathing frequency
Less than daily 23 (2.1) 22 (2.0)
Daily 1063 (97.9) 1062 (98.0)
Data are no. (%) of subjects or median value (interquartile range; range).
Numbers and percentages may not sum up to totals due to missing values
and rounding.
a Data are for 1004 subjects in the circumcision arm and 1016 subjects in the
control arm.
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incident HPV-16 and HPV-18 loads in the circumcision versus
control arms were assessed using the Wilcoxon rank sum test.
RESULTS
Characteristics of men enrolled in this RCT have been previous-
ly described [14, 16, 21]. Briefly, the median age of eligible study
participants was 20 years (range, 18–24 years). Most men were
unemployed (65%) and unmarried (93%). There were no appre-
ciable differences in sociodemographic characteristics, sexual
history, or results of laboratory tests for sexually transmitted in-
fections at baseline between eligible participants randomly as-
signed to the circumcision and control arms (Table 1).
Incidence of High-HPV Viral Load Infections
The 24-month cumulative risk of high-viral load infections in
the glanswas lower in the circumcision arm, comparedwith con-
trol arm, for HPV-16 (2.7% vs 9.5%; P < .001, by the log-rank
test) and HPV-18 (2.2% vs 6.8%; P < .001, by the log-rank test;
Figure 2). In the shaft, the estimated 24-month cumulative risk
of high-viral load infections was comparable in the circumci-
sion and control arms for HPV-16 (2.0% and 2.6%, respectively;
P = .46, by the log-rank test) and HPV-18 (2.0% and 2.6%, re-
spectively; P = .53, by the log-rank test). Few men had incident
infections in both the glans and shaft (19% for HPV-16 and
25% for HPV-18), and in all of these cases the viral load category
(high or low viral load) was the same in both anatomical sites.
Of incident HPV infections observed, 151 (39.7%) with a
high HPV-16 load and 135 (69.2%) with a high HPV-18 load
occurred in either the glans or shaft (Table 2). The rate of ac-
quisition of high-viral load infections in the glans was lower in
the circumcision arm, compared with the control arm, for both
HPV-16 (HR, 0.32 [95% confidence interval {CI}, .20–.49]) and
HPV-18 (HR, 0.34 [95% CI, .21–.54]). Weaker results were ob-
served in the shaft for both HPV types (HRs, 0.79 [95% CI, .42–
1.45] for HPV-16 and 0.87 [95% CI, .48–1.54] for HPV-18).
Figure 2. Estimated cumulative incidence of high-viral load human papillomavirus (HPV) infections, by anatomical site over 24 months in Kenyan men.
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Sensitivity analyses restricted to β-globin–positive samples
yielded similar results (Table 2). Sensitivity analyses examining
incident HPV viral load as a continuous variable also found that
the median HPV viral load was lower in the circumcision arm,
compared with the control arm, for incident HPV-16 infection
(250 vs 450 copies/scrape) and incident HPV-18 infection (250
Table 2. Estimated Effect of Circumcision on Incidence of High-Viral Load Human Papillomavirus 16 (HPV-16) and HPV-18 Infections Over
24 Months in Kenyan Men
HPV Type, Anatomical
Site, Treatment Arm
All Samples β-globin–Positive Samples
Incident High-Viral Load
Infections,a No. HRb (95% CI)
Incident High-Viral Load
Infections,a No. HRb (95% CI)
HPV-16
Glans
Circumcision 26 0.32 (.20–.49) 19 0.29 (.17–.56)
Control 83 1 72 1
Shaft
Circumcision 18 0.79 (.42–1.45) 9 0.76 (.31–1.76)
Control 24 1 13 1
HPV-18
Glans
Circumcision 22 0.34 (.21–.54) 15 0.38 (.21–.70)
Control 66 1 45 1
Shaft
Circumcision 21 0.87 (.48–1.54) 11 0.67 (.31–1.42)
Control 26 1 17 1
Abbreviation: CI, confidence interval.
a Incident infection was defined as the first type-specific HPV-positive result in men who were negative for that HPV type at the same anatomical site at baseline. A
high HPV viral load was defined as >250 copies/scrape for the given HPV type.
b Hazard ratios (HRs) reflect comparisons of the risk of incident high-HPV viral load infections for the circumcision arm vs that for the control arm.




All Samples, by HPV Viral Loada β-globin–Positive Samples, by HPV Viral Loada
High Low PRb (95% CI) High Low PRb (95% CI)
HPV-16
Glans
Circumcision 26 43 0.70 (.50–.99) 19 26 0.72 (.53–.98)
Control 83 72 1 72 51 1
Shaft
Circumcision 18 52 0.93 (.55–1.57) 9 22 0.92 (.45–1.86)
Control 24 62 1 13 28 1
HPV-18
Glans
Circumcision 22 24 0.59 (.43–.82) 15 16 0.59 (.40–.87)
Control 66 16 1 45 10 1
Shaft
Circumcision 21 6 1.20 (.88–1.62) 11 3 1.25 (.84–1.86)
Control 26 14 1 17 10 1
Abbreviation: CI, confidence interval.
a Incident infection was defined as the first type-specific HPV-positive result in men who were negative for that HPV type at the same anatomical site at baseline. A
high HPV viral load was defined as >250 copies/scrape for the given HPV type; low viral load was defined as ≤250 copies/scrape for the given HPV type.
b Prevalence ratios (PRs) reflect comparisons of the prevalence of high vs low viral load at HPV detection in men with incident HPV infections in the circumcision arm
vs the control arm.
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vs 7326 copies/scrape) in the glans but not for incident infec-
tion in the shaft (Supplementary Table 1).
Prevalence of High Versus Low HPV Viral Load at Detection
of Incident HPV Infections
Among men with incident HPV infections in the glans, the
prevalence of high versus low viral load at the time of HPV de-
tection was lower in the circumcision arm, compared with the
control arm, for HPV-16 (PR, 0.70 [95% CI, .50–.99]) and
HPV-18 (PR, 0.59 [95% CI, .43–.82]; Table 3). However, this as-
sociation was not observed in the shaft for HPV-16 (PR, 0.93
[95% CI, .55–1.57]) or HPV-18 (PR, 1.20 [95% CI, .88–1.62]).
PRs obtained after adjustment for HIV infection, condom use,
number of sex partners, bathing frequency, presence of sexually
transmitted infections, and multiple HPV type infection were
similar to the reported unadjusted HRs (results not shown).
Sensitivity analyses restricted to β-globin–positive samples
showed similar results as the main analysis (Table 3).
Persistence of High-Viral Load and Low-Viral Load HPV
Infections Prevalent at Baseline
For both HPV types, the prevalence at baseline was higher in
the glans (6.6% for HPV-16 and 3.1% for HPV-18), compared
with the shaft (2.8% for HPV-16 and 1.1% for HPV-18).
Table 4. Persistence of Baseline Prevalent Human Papillomavirus (HPV) Infections, by HPV Type, Anatomic Site, HPV Viral Load, and
Treatment Arm, in Kenyan Men
HPV Type, Anatomical Site, HPV





Estimated 6-mo Risk of HPV
Persistencec (95% CI)





Circumcision 35/35 14.4 0.20 (.09–.34) 0.36 (.18–.72)
Control 40/44 23.8 0.55 (.39–.68) 1
Low
Circumcision 33/33 9.2 0 . . .
Control 31/32 9.3 0.13 (.04–.26)
Shaft
High
Circumcision 5/5 1.3 0 . . .
Control 3/3 2.2 0.67 (.05–.94)
Low
Circumcision 34/34 12.1 0.09 (.02–.19) 1.06 (.20–5.53)




Circumcision 24/24 9.1 0.17 (.05–.34) 0.34 (.13–0.86)
Control 16/16 10.8 0.50 (.35–.71) 1
Low
Circumcision 13/13 3.9 0.08 (.00–.29) 0.57 (.05–6.44)
Control 7/7 2.5 0.14 (.01–.46) 1
Shaft
High
Circumcision 4/4 1.0 0 . . .
Control 6/6 2.3 0.15 (.01–.52)
Low
Circumcision 8/8 2.5 0 . . .
Control 6/6 1.5 0
Abbreviation: CI, confidence interval.
a High HPV viral load was defined as >250 copies/scrape, and low HPV viral load was defined as ≤250 copies/scrape.
b Data are no. of cleared HPV infections/total no. of HPV infections at baseline.
c Persistence was defined as an HPV-positive result in participants who were positive for that given HPV type at the same anatomical site in the previous visit.
Estimates for risks of persistence and duration since baseline visit were obtained from Kaplan–Meier graphs.
d Risk ratio (RR) comparing estimated risk of HPV persistence in the circumcision arm vs that in the control arm. Ellipses denote RRs that could not be calculated
because all HPV infections in at least 1 group had cleared at 6 months after HPV detection.
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Prevalent infections in the glans at baseline were more likely to
have high HPV viral loads (54.9% [79] for HPV-16 and 66.7%
[40] for HPV-18) than prevalent infections at baseline in the
shaft (11.9% [8] for HPV-16 and 41.7% [10] for HPV-18;
Table 4). Similar proportions of men with prevalent HPV-16
and HPV-18 infections at baseline were assigned to the circum-
cision and control arms (Figure 1).
Nearly all prevalent infections at baseline cleared during the
24 months of follow-up, with the exception of 5 HPV-16 glans
infections (6.6%) in the control arm (4 high-viral load infec-
tions censored at 18 months and 1 low-viral load infection cen-
sored at 12 months after baseline). For both HPV types, most
prevalent infections in the glans or shaft cleared within 6
months (Figure 3 and Supplementary Figure 1). The estimated
risk of persistence to 6 months for prevalent HPV infections in
the glans was lower in the circumcision arm, compared with the
control arm, for HPV-16 (RR, 0.36 [95% CI, .18–.72]) and
HPV-18 (RR, 0.34 [95% CI, .13–.86]; Table 4). The estimated
risk of persistence to 6 months for high-viral load infections
in the circumcision arm (0.20 [95% CI, .09–.34]) was similar
to that for low-viral load infections in the control arm (0.13
[95% CI, .04–.26]) for prevalent HPV-16 infections in the
glans. A similar trend was observed for prevalent HPV-16 infec-
tions in the shaft and for prevalent HPV-18 infections in the
glans and shaft. Sensitivity analyses of HPV persistence restrict-
ed to prevalent infections that were β-globin positive found re-
sults similar to those from the main analysis (data not shown).
DISCUSSION
The 2-year cumulative incidence of high-viral load HPV-16 and
HPV-18 infections in the glans was lower in the male circum-
cision arm, compared with the control arm, in young men from
Kisumu. Male circumcision reduced the rate of acquisition of
high-viral load HPV-16 and HPV-18 infections in the glans
over 24 months. Among men with incident HPV-16 or HPV
Figure 3. Estimated clearance of prevalent high-viral load human papillomavirus (HPV) infection, by circumcision status, in Kenyan men.
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18 infections, those who were circumcised were more likely than
uncircumcised men to have low-viral load infections, rather
than high-viral load infections, in the glans over 24 months.
We also found that for prevalent high-viral load infections de-
tected at baseline, the risk of persistence to 6 months was lower
in the circumcision arm, compared with the control arm, for
both HPV-16 and HPV-18 in the glans. Weaker and less precise
results were observed for the estimated effect of male circumci-
sion on the incidence of high-load HPV-16 and HPV-18 infec-
tions in the shaft samples.
To our knowledge, only one other study, the male circumcision
trial conducted in Rakai, Uganda, has examined the effect of male
circumcision on the HPV viral load in men [20]. The study found
that the combined HPV viral load for HPV-16, HPV-18, HPV-
31, HPV-33, HPV-35, and HPV-52 in the glans was lower in
the circumcision arm, compared with the control arm, at 24
months after randomization. Their estimated protective effect of
circumcision on the point prevalence of high-viral load versus
low-viral load HPV infections in the glans (PR, 0.54 [95%
CI, .21–1.42]) was similar to the 24-month period prevalence
estimates we obtained for incident high-viral load infection,
compared with incident low-viral load infection of HPV-16
(0.70 [95%, .50–.99]) and HPV-18 (0.59 [95% CI, .43–.82]) in
the glans.
Our study examined HPV viral load in both the glans and shaft
of the penis. The estimated effects of male circumcision in reduc-
ing the incidence and risk of persistence of high-viral load infec-
tions in the shaft were weaker and less precise than estimated
effects for the glans. This may be due to a lower proportion of
high-HPV viral load infections detected in the shaft, compared
with the glans. Stronger effects of male circumcision on HPV in-
fection have been previously observed in the glans, compared with
anatomical sites more distal to the foreskin [18].
The biologicalmechanism bywhichmale circumcision reduces
the viral load of HPV is unclear. It has been hypothesized that
the keratinized skin surface and scar tissue in circumcised men
reduces the entry of HPV and subsequent HPV replication in
the basal epidermal cells of the penis [26]. In uncircumcised
men, the moist subpreputial cavity may promote HPV survival
and subsequently increase the risk of HPV persistence [26, 27].
Male circumcision has been previously shown to reduce the prev-
alence of flat penile lesions; our findings are consistent with the
current understanding that male circumcision reduces the prev-
alence of flat penile lesions by reducing the HPV viral load in
men [9–11]. Furthermore, the effect of male circumcision in
reducing the HPV viral load may explain why fewer HPV infec-
tions and lower HPV viral loads are observed in female partners
of circumcised men, compared with those of uncircumcised men
[19, 27]. It is plausible that male circumcision reduces the risk of
transmission of HPV infections to women by reducing incidence
and persistence of high-HPV viral load infections in their male
partners.
The main strengths of this study include the extensive longi-
tudinal data on HPV viral load collected every 6 months for
2 years and the performance of quantitative HPV viral load
measurements by real-time PCR. Our study is also the first to
examine the type-specific HPV viral load in both the glans
and shaft of the penis. Our main study limitation is that HPV
viral load measurements were not normalized to account for the
number of cells in each swab sample (viral load copies/cell).
However, the copies/scrape units have been previously used to
show that a high HPV viral load (ie, >250 copies/scrape) in men
is associated with a higher prevalence of flat penile lesions and
greater HPV type concordance in their female partners [9, 10].
Furthermore, sensitivity analyses examining the HPV viral load
in incident infections as a continuous variable found similar re-
sults as the main analyses that used the 250 copies/scrape cut
point. We also observed fairly low β-globin positivity in our
samples (61.5% in glans samples and 43.5% in shaft samples).
A possible explanation is that penile cells, particularly in shaft
samples, are more keratinized and anucleated than those in the
cervix, and therefore may contain less human DNA [28]. A
lower frequency of β-globin positivity in penile swab samples
has also been documented in a similar study [17]. Because of
the fairly low frequency of beta-globin positivity in our study, it
is possible that the HPV viral load measurements in this study
may be underestimated. However, all of the incidence and persis-
tence sensitivity analyses restricted to β-globin–positive samples
found results similar to those of the main analyses.
Interestingly, high-viral load infections appeared to have a high-
er risk of HPV persistence than low-viral load infections, irrespec-
tive of circumcision status. This may be due to the greater number
of virus-infected cells that the immune system has to eliminate for
high-viral load infections, compared with low-viral load infections,
although this needs to be confirmed in a larger study that accounts
for other factors associated with HPV clearance.
In conclusion, this study showed that male circumcision reduc-
es the hazard of acquisition and risk of persistence of high-HPV
viral load penile infections in the glans in Kenyan men. High
HPV viral load in men is suggested to be associated with an in-
creased risk of HPV transmission to female partners [9]. There-
fore, male circumcision could potentially reduce the risk of HPV
transmission to women by reducing the hazard of acquisition and
risk of persistence of high-HPV viral load infections in men.
These findings support the effectiveness of male circumcision as
an intervention to reduce the incidence and risk of persistence of
high-viral load HPV infections in men and, potentially, the inci-
dence of subsequent HPV infection in their sexual partners.
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